Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
2
×
boston top stories
detroit blog main
detroit top stories
drugs
life sciences
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
accelerator
airbnb
alder biopharmaceutical
allergan
amazon web services (aws)
american academy of neurology
amgen
artificial intelligence (a.i.)
athelas
atogepant
atomwise
benchling
biohaven
biotech
biotechnology
bob azelby
botox
boulder/denver blog main
What
big
2
×
companies
2
×
admits
ago
approval
arguments
biotechs
class
classes
combinator
commercialized
competitors
decades
drug
drugs
dug
fda
incubator
life
make
meeting
migraine
neuro
new
oral
potential
previously
sciences
sizable
started
startup
tech
therapies
they’re
welcome
won
year
years
Language
unset
Current search:
companies
×
big
×
" boston blog main "
×
@xconomy.com
4 years ago
Five Years After Y Combinator First Admits Biotechs, They’re Dug In
@xconomy.com
5 years ago
At Big Neuro Meeting, Migraine Drug Competitors to Make Oral Arguments